Site Map
Site Map of
http://www.researchandmarkets.com
-
Site Map
-
Pharmaceuticals and Healthcare
-
Pharmaceuticals 1
(
Latest Titles
)
Pharmaceuticals 2
Pharmaceuticals 3
Pharmaceuticals 4
-
Drug Delivery
<< You are in This Category
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
#
2006 US Market Advanced Drug Delivery Systems Probing the Route to Growth
static version
printer friendly
pdf version
^ Top
A
AmerisourceBergen Business Intelligence Report
static version
printer friendly
pdf version
Antitargets: Prediction and Prevention of Drug Side Effects
static version
printer friendly
pdf version
Asia-Pacific Drug Delivery
static version
printer friendly
pdf version
^ Top
B
Bipolar Disorder: Can Competitive Advantage Be Established in a Challenging Market
static version
printer friendly
pdf version
^ Top
C
Canadian Online Pharmacies Market Overview
static version
printer friendly
pdf version
Cancer Drug Delivery: Managing Cancer Patients Beyond Oral Formulation
static version
printer friendly
pdf version
Cancer Drug Discoveries: What the Future Holds: Non-Small Cell Lung Cancer Chapter
static version
printer friendly
pdf version
Cardinal Health Business Intelligence Report 2007
static version
printer friendly
pdf version
Cardiovascular Drug Delivery - Technologies, Markets and Companies
static version
printer friendly
pdf version
Cell Signalling Pathways - Productive Sources of Pharmaceutical Targets
static version
printer friendly
pdf version
Chinese Markets for Drug Delivery Systems
static version
printer friendly
pdf version
Commercial and Pipeline Perspectives: Lower GI Disorders - Remicade Leads Growth as Novel Biologics Compete for Market Share in Inflammatory Bowel Disease
static version
printer friendly
pdf version
Commercial and Pipeline Perspectives: Rheumatoid Arthritis - Novel Biologics Drive Innovation in the Global RA Market
static version
printer friendly
pdf version
Cost per Million Injections by Injector Type
static version
printer friendly
pdf version
^ Top
D
Degradation Rate of Bioresorbable Materials
static version
printer friendly
pdf version
Diabetes and Pregnancy - Delivering Improved Outcomes
static version
printer friendly
pdf version
Diabetes Drug Delivery Methods - Market and Technologies
static version
printer friendly
pdf version
Diabetes Mellitus – Evaluation and Management 2007 Update
static version
printer friendly
pdf version
Does the Treatment of Huntingtons Disease Represent a Commercial Opportunity?
static version
printer friendly
pdf version
Drug Delivery - Analysis of Cutting-Edge Technologies and Trends
static version
printer friendly
pdf version
Drug Delivery - Snapshots and Highlights
static version
printer friendly
pdf version
Drug Delivery 2000: A Key Company and Market Analysis
static version
printer friendly
pdf version
Drug Delivery in Asia-Pacific
static version
printer friendly
pdf version
Drug Delivery in Belgium
static version
printer friendly
pdf version
Drug Delivery in Canada
static version
printer friendly
pdf version
Drug Delivery in Cancer - Technologies, Markets and Companies
static version
printer friendly
pdf version
Drug Delivery in Central Nervous System Diseases - Technologies, Markets and Companies
static version
printer friendly
pdf version
Drug Delivery in China
static version
printer friendly
pdf version
Drug Delivery in Europe
static version
printer friendly
pdf version
Drug Delivery in France
static version
printer friendly
pdf version
Drug Delivery in Germany
static version
printer friendly
pdf version
Drug Delivery in Italy
static version
printer friendly
pdf version
Drug Delivery in Japan
static version
printer friendly
pdf version
Drug Delivery in Spain
static version
printer friendly
pdf version
Drug Delivery in the Netherlands
static version
printer friendly
pdf version
Drug Delivery in the United Kingdom
static version
printer friendly
pdf version
Drug Delivery in the United States
static version
printer friendly
pdf version
Drug Delivery Report - Winter 2007/2008
static version
printer friendly
pdf version
Drug Delivery Review 2000/2001
static version
printer friendly
pdf version
Drug Delivery Systems in Cancer Therapeutics
static version
printer friendly
pdf version
Drug Delivery Systems in Cardiovascular Therapeutics
static version
printer friendly
pdf version
Drug Delivery Systems: US Market Outlook, Advances for Pharma, Biotech & Medical Devices
static version
printer friendly
pdf version
Drug Discovery and Development, Volume 2, Drug Development
static version
printer friendly
pdf version
Drug Transporters: Molecular Characterization and Role in Drug Disposition
static version
printer friendly
pdf version
Drug Wholesalers Market Overview
static version
printer friendly
pdf version
Drug-Drug Interactions in Pharmaceutical Development
static version
printer friendly
pdf version
Drugs of Tomorrow 2001: Bacterial Infections
static version
printer friendly
pdf version
Drugs of Tomorrow 2001: Diabetes
static version
printer friendly
pdf version
Drugs of Tomorrow 2001: Neuroprotection - Future Strategies for Success
static version
printer friendly
pdf version
Drugs of Tomorrow: Anti-asthmatics - Enter the mAbs
static version
printer friendly
pdf version
Drugs of Tomorrow: Antipsychotics - Gaining Competitive Advantage From a Limited Research Base
static version
printer friendly
pdf version
^ Top
E
Effective Licensing & Commercialisation of Drug Delivery Systems 2006
static version
printer friendly
pdf version
Emerging Opportunities in Inhalation & Nasal Spray Generic Drugs
static version
printer friendly
pdf version
Emerging Technologies in Drug Delivery (Technical Insights)
static version
printer friendly
pdf version
Emerging Technologies in Drug Delivery Devices and Implantable Pain Management
static version
printer friendly
pdf version
Endometriosis - Growing the Patient Population is Key to Unlocking the Markets Commercial Potential
static version
printer friendly
pdf version
European Drug Delivery
static version
printer friendly
pdf version
European Testosterone Replacement Therapies Markets
static version
printer friendly
pdf version
Evolving Approaches for Protein Drug Delivery
static version
printer friendly
pdf version
^ Top
G
Global Drug Delivery
static version
printer friendly
pdf version
Global Transdermal Drug Delivery Market Size, 2007-2012
static version
printer friendly
pdf version
^ Top
I
Impact of Nano Materials in Drug Delivery & Human Tissue Engineering
static version
printer friendly
pdf version
Injectable Drug Delivery: Probing the Route to Growth
static version
printer friendly
pdf version
Innovation in Drug Delivery: The Future of Nanotechnology and Non-invasive Protein Delivery
static version
printer friendly
pdf version
Innovations in Drug Delivery Within the Respiratory Market: The Key to Effective Lifecycle Management?
static version
printer friendly
pdf version
Intranasal Drug Delivery - Global Strategic Business Report
static version
printer friendly
pdf version
^ Top
K
Key Trends in European Patient Monitoring Systems Market
static version
printer friendly
pdf version
KeywordPharma Conference Insights - Reporting Adverse Events
static version
printer friendly
pdf version
^ Top
M
McKesson Corporation Business Intelligence Report 2007
static version
printer friendly
pdf version
Medication Reconciliation Strategies to Reduce Hospital Adverse Drug Events
static version
printer friendly
pdf version
^ Top
N
Nano Drug Delivery: The Impact of Nanotechnology in Drug Delivery: Global Developments, Market Analysis and Future Prospects
static version
printer friendly
pdf version
^ Top
O
Opportunities and Challenges for Generic Drugs in the UK 2007
static version
printer friendly
pdf version
Opportunities in R&D 2001
static version
printer friendly
pdf version
Organic and Medicinal Chemistry in Drug Discovery: Pharma's Intelligent Design
static version
printer friendly
pdf version
Overcoming Formulations Challenges: Novel Techniques for Optimum Results
static version
printer friendly
pdf version
^ Top
P
Pain Therapeutics: New Times, New Targets
static version
printer friendly
pdf version
Partneringreview 2006: Biopharma Deal Making By Industry Sector - Drug Delivery
static version
printer friendly
pdf version
PharmaVitae 2001: Andrx
static version
printer friendly
pdf version
PharmaVitae 2001: Inhale Therapeutic Systems
static version
printer friendly
pdf version
PharmaVitae 2001: Mylan Laboratories
static version
printer friendly
pdf version
PharmaVitae 2001: Powderject
static version
printer friendly
pdf version
PharmaVitae 2001: RP Scherer
static version
printer friendly
pdf version
PharmaVitae 2001: SkyePharma
static version
printer friendly
pdf version
PharmaVitae 2002: Gilead Sciences
static version
printer friendly
pdf version
Pipeline And Commercial Insight: Influenza Vaccines - Pandemic Threat Revitalizes The Sector
static version
printer friendly
pdf version
Pipeline Insight: Alzheimers Disease - A Busy Future, with Diagnosis, Disease Modification and Prevention Key to Growing Market
static version
printer friendly
pdf version
Pipeline Insight: Antihypertensives - Together We Stand, Divided We Fail
static version
printer friendly
pdf version
Pipeline Insight: Diabetes Drug Delivery and Diagnostics - Towards the Non-invasive Revolution
static version
printer friendly
pdf version
Pipeline Insight: Hematological Malignancies - Targeted Treatments And Immunotherapy Infuse New Blood
static version
printer friendly
pdf version
Pipeline Insight: Multiple Sclerosis - The Oral Revolution
static version
printer friendly
pdf version
Protein Drug Delivery: Penetrating a Growth Market
static version
printer friendly
pdf version
Pulmonary Delivery of Therapeutics - State-of-the-Science and Strategic Opportunities
static version
printer friendly
pdf version
Pulmonary Drug Delivery Technologies - Global Strategic Business Report
static version
printer friendly
pdf version
^ Top
R
Role of Lipid Excipients in Modifying Oral and Parenteral Drug Delivery: Basic Principles and Biological Examples
static version
printer friendly
pdf version
^ Top
S
Sector Snapshot: Demand for Drug Delivery Systems
static version
printer friendly
pdf version
Share of Worldwide Prefilled Syringe Market by Competitor
static version
printer friendly
pdf version
Short Protocols in Pharmacology and Drug Discovery
static version
printer friendly
pdf version
^ Top
T
Targeted Drug Delivery Technologies: Players, products & prospects to 2015
static version
printer friendly
pdf version
The Drug Delivery Outlook 2001
static version
printer friendly
pdf version
The Drug Delivery Sector: Reformulating Company Strategies for the Future
static version
printer friendly
pdf version
The Future of Array Technologies: Impact on Drug Discovery and Market Growth in DNA, Protein
static version
printer friendly
pdf version
The Pharmaceutical Licensing Outlook: A Strategic Guide To Effective Deal-Making And Profitable Partnerships
static version
printer friendly
pdf version
The Rationale Behind Drug Reformulation: Five Case Studies and Overview of CNS Market and R&D
static version
printer friendly
pdf version
The Top 100 Drug Delivery Companies Worldwide
static version
printer friendly
pdf version
Transdermal & Transmucosal Delivery of Therapeutics, 2nd Edition
static version
printer friendly
pdf version
Transdermal Drug Delivery - Technologies, Markets, and Companies
static version
printer friendly
pdf version
Transmembrane Transporters: High Sales, High Potential as Drug Targets
static version
printer friendly
pdf version
Trends in the Commercialization of Biomarkers: Tests and Companies
static version
printer friendly
pdf version
^ Top
U
U.S. Diabetes Delivery Systems Markets
static version
printer friendly
pdf version
U.S. Drug Delivery Systems Market: Emerging Technologies, Strategic Alliances, Patent Disputes, Market Size and Forecasts and R&D Activities
static version
printer friendly
pdf version
U.S. Drug Delivery Technology Markets
static version
printer friendly
pdf version
U.S. Emerging Pulmonary Drug Delivery Technologies Markets
static version
printer friendly
pdf version
U.S. Intranasal Drug Delivery Market
static version
printer friendly
pdf version
U.S. Transdermal Drug Delivery Markets
static version
printer friendly
pdf version
US Markets for Drug Delivery
static version
printer friendly
pdf version
US Markets for Drug Delivery - Executive Summary
static version
printer friendly
pdf version
^ Top
V
Vaccine Adjuvants and Delivery Systems
static version
printer friendly
pdf version
^ Top
W
Who's Developing What in Drug Delivery?
static version
printer friendly
pdf version
Worldwide Cancer Drug Delivery Market, 2005-2015
static version
printer friendly
pdf version
Worldwide Market for Injectable/Implantable Drug Delivery Systems by Pharmaceutical and Drug Delivery Component, 1995-2005
static version
printer friendly
pdf version
Worldwide Market for Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005
static version
printer friendly
pdf version
Worldwide Market for Injectable/Implantable Drug Delivery Systems Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005
static version
printer friendly
pdf version
Worldwide Market for Injectable/Implantable Drug Delivery Systems Market Share by Type, 1995-2005
static version
printer friendly
pdf version
Worldwide Market for Needle-Free Injectable Drug Delivery Systems, 1995-2005
static version
printer friendly
pdf version
Worldwide Needleless Injector Dollar Volume, 1998-2006
static version
printer friendly
pdf version
Worldwide Prefilled Syringe Dollar Volume, 1998-2006
static version
printer friendly
pdf version
Worldwide Prefilled Syringe Unit Sales, 1998-2006
static version
printer friendly
pdf version
Worldwide Safety Syringe Unit Sales, 1998-2006
static version
printer friendly
pdf version
All rights reserved. © copyright 2006 Research and Markets
Terms and conditions
Privacy Policy